BioSpace News Archive

Business

Trans-Hit Bio and Q&T Research enter into an Exclusive Strategic Business Partnership

Trans-Hit Bio (THB) is pleased to announce a strategic partnership with Q&T Research to facilitate access by the biopharma community to large quantities of blood collected by plasmapheresis from healthy donors and ambulatory patients that can be used to prepare the large volumes of PBMC.

March 7, 2018
·
1 min read
Business

Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer

Eloxx Pharmaceuticals, Inc. (“Eloxx”) (OTCQB: SVOND), a clinical-stage biopharmaceutical company developing novel small molecule medicines...

March 7, 2018
·
5 min read
Business

Eloxx Pharmaceuticals Appoints Biotech Leader, Dr. Jasbir Seehra, Co-founder of Acceleron Pharma, to Board of Directors

Eloxx Pharmaceuticals, Inc. (“Eloxx”), (ELOX) (Other OTC:SVOND) a clinical-stage biopharmaceutical company developing novel read-through drug candidates that are designed to treat rare and ultra-rare premature...

March 7, 2018
·
4 min read
Business

Aevi Genomic Medicine Expands Collaboration with Kyowa Hakko Kirin

Early stage program in an ultra-orphan pediatric indication with potential to expand to additional indications post proof of concept.

March 7, 2018
·
4 min read
Deals

Alliance PT Completes Acquisition of Agility Health’s U.S. Operations

Closing the Acquisition Opens New Chapter for GPB Capital Affiliate, Bringing a Network of High-Quality Physical Therapy/Rehabilitation Clinics & Care Providers onto the Alliance PT Platform

March 7, 2018
·
4 min read
Business

HeartFlow Announces Collaborative Research Agreement with Imperial College London

Joint research in medical imaging and deep learning to help improve treatment planning for patients with heart disease

March 7, 2018
·
4 min read